AI Model Revolutionizes Cancer Research with Cellular-Level Insights
BioTuring's AI model offers detailed cellular visualizations of cancer, enhancing understanding of tumor dynamics and aiding drug development, according to...
DRUG DEVELOPMENT
AI Model TxGNN Utilizes Zero-Shot Learning to Repurpose Drugs for Rare Diseases
Harvard scientists develop TxGNN, an AI model using zero-shot learning to identify new uses for existing drugs, potentially closing treatment...
